Skip to main content
OpenTrials

Clinical trial condition

NHL

Explore clinical trials studying NHL. Study availability and eligibility vary by location and protocol.

24 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

NHL trial results

Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New Orleans, Louisiana, United States
View Trial Details
Completed

Safety Study of NHL With 90Y-hLL2 IgG

NCT00421395

Conditions
B-cell NHL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Unit 463 INSERM Nantes, Cedex, France
  • Service des Maladies du Sang Lille, France
  • University Hospital Dresden Dresden, Germany
  • Klinikum der Georg-August-Universitat Gottingen Göttingen, Germany
View Trial Details
Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details

Related conditions